ScalmiBio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $6.5M

ScalmiBio General Information

Description

Operator of an early-stage biotechnology company intended to develop transformational technology focusing on oncology applications. The company's novel technology converts therapeutic antibodies into pro-drugs activated specifically within the tumor and restricts their activity to the tumor micro-environment, enabling the practitioners to make the broader use of combination treatments, higher therapeutic doses, and limit side effects.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • MBC Biolabs
  • 733 Industrial Road
  • San Carlos, CA 94070
  • United States
Primary Industry
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • MBC Biolabs
  • 733 Industrial Road
  • San Carlos, CA 94070
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ScalmiBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 04-Oct-2021 $6.5M Completed Generating Revenue
3. Accelerator/Incubator 03-May-2019 Completed Startup
2. Grant 11-Mar-2019 $2.21M Completed Startup
1. Grant 01-Jan-2019 $300K Completed Startup
To view ScalmiBio’s complete valuation and funding history, request access »

ScalmiBio Patents

ScalmiBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018213335-A1 Activatable antibodies and methods of use thereof Inactive 16-May-2017

ScalmiBio Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
California Life Sciences Accelerator/Incubator
MBC BioLabs Accelerator/Incubator
U.S. Department of Health and Human Services Government
To view ScalmiBio’s complete investors history, request access »

ScalmiBio FAQs

  • When was ScalmiBio founded?

    ScalmiBio was founded in 2018.

  • Where is ScalmiBio headquartered?

    ScalmiBio is headquartered in San Carlos, CA.

  • What industry is ScalmiBio in?

    ScalmiBio’s primary industry is Biotechnology.

  • Is ScalmiBio a private or public company?

    ScalmiBio is a Private company.

  • What is the current valuation of ScalmiBio?

    The current valuation of ScalmiBio is .

  • What is ScalmiBio’s current revenue?

    The current revenue for ScalmiBio is .

  • Who are ScalmiBio’s investors?

    California Life Sciences, MBC BioLabs, and U.S. Department of Health and Human Services have invested in ScalmiBio.

  • When was ScalmiBio acquired?

    ScalmiBio was acquired on 04-Oct-2021.

  • Who acquired ScalmiBio?

    ScalmiBio was acquired by ALX Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process